Impact of daratumumab/bortezomib/thalidomide and dexamethasone induction therapy on chemo-free stem cell mobilization in transplant eligible newly diagnosed multiple myeloma: a multicentre real-world experience.
Porrazzo M, Moscato T, Sapienza G, Accardi F, Patti C, Cangialosi C, Costanza C, Bono R, Tringali S, Rotolo C, Gigliotta E, Rizzuto A, Ingrascè MG, Butera G, Di Noto L, Santoro A, Marfia A, Botta C, Siragusa S, Martino M, Castagna L.
Porrazzo M, et al. Among authors: martino m.
Haematologica. 2024 Oct 31. doi: 10.3324/haematol.2024.286332. Online ahead of print.
Haematologica. 2024.
PMID: 39479867
Free article.